meglumine-ioglicinate and Infant--Newborn--Diseases

meglumine-ioglicinate has been researched along with Infant--Newborn--Diseases* in 1 studies

Other Studies

1 other study(ies) available for meglumine-ioglicinate and Infant--Newborn--Diseases

ArticleYear
[The use of a new renotropic contrast-medium in infants with special reference to magnesium metabolism (author's transl)].
    Der Radiologe, 1979, Volume: 19, Issue:3

    Rayvist is the meglumine ioglicinate. This contrast medium is compared with Urovist in two groups of 15 infants. Electrolyte and osmolality changes in both groups are equal. In infants receiving Rayvist there were less gastro-intestinal distrubances than in those receiving Urovist. The drop of magnesium level in both groups is similar to the drop of calcium level following contrast medium injection. It is recommended to add calcium to the contrast medium in infants (1 ccm Calcium gluconicum 10% for 10 ccm contrast medium).

    Topics: Calcium; Contrast Media; Digestive System; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Iothalamic Acid; Magnesium; Meglumine; Urography; Urologic Diseases

1979